Intercure(INCR.US)

Last Updated 19:00:00 ET
longbridge loading

InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow | INCR Stock News

StockTitan·
US
INCR
+0.59%
StockTitan·
US
INCR
+0.59%

Extendicare Sets Date for Q1 2026 Results and Investor Call

Tip Ranks·
US
ICCM
+3.29%
US
IHI
+1.23%
US
INCR
+0.59%
Tip Ranks·
US
ICCM
+3.29%
US
IHI
+1.23%
US
INCR
+0.59%

Photocure leverages EAU 2026 trials to cement role in precision bladder cancer care

Tip Ranks·
US
INCR
+0.59%
US
ICCM
+3.29%
US
CUBT
+0.63%
Tip Ranks·
US
INCR
+0.59%
US
ICCM
+3.29%
US
CUBT
+0.63%

InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement | INCR Stock News

StockTitan·
US
INCR
+0.59%
StockTitan·
US
INCR
+0.59%

InterCure Posts Higher 2025 Revenue and EBITDA, Resumes Nir Oz Output and Advances Expansion Plans

Tip Ranks·
US
INCR
+0.59%
Tip Ranks·
US
INCR
+0.59%

Why Investors Shouldn't Be Surprised By InterCure Ltd.'s (TLV:INCR) 29% Share Price Plunge

Simplywall·
US
INCR
+0.59%
Simplywall·
US
INCR
+0.59%

U.S. stock market midday update: Intercure's stock price soared 16.48%, trading volume surged, and sector trends have attracted market attention?

Price Alert·
US
INCR
+0.59%
Price Alert·
US
INCR
+0.59%
© 2026 Longbridge｜Disclaimer